{"title":"斯里兰卡家族性高胆固醇血症：解决证据差距，铺平道路。","authors":"Anne Thushara Matthias","doi":"10.1016/j.jacl.2025.06.025","DOIUrl":null,"url":null,"abstract":"<p><p>In recent years, South Asia has witnessed a staggering increase in the rate of cardiovascular (CV) deaths, overburdening healthcare systems in this low- to middle-income region. Dyslipidemia is a major risk factor for cardiovascular disease (CVD). Identifying potential gaps in screening and managing dyslipidemia could help to develop a framework for CVD management in this region. Among dyslipidemias, familial hypercholesterolemia (FH) is a risk factor for premature CVD. Data on FH in Sri Lanka, a South Asian country, are sparse. This report is the first to identify and address problems associated with FH in Sri Lanka. It provides insight into the practices employed within the country and helps assess potential barriers in managing patients with FH.</p>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Familial hypercholesterolemia in Sri Lanka: Addressing evidence gaps and paving the road ahead.\",\"authors\":\"Anne Thushara Matthias\",\"doi\":\"10.1016/j.jacl.2025.06.025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In recent years, South Asia has witnessed a staggering increase in the rate of cardiovascular (CV) deaths, overburdening healthcare systems in this low- to middle-income region. Dyslipidemia is a major risk factor for cardiovascular disease (CVD). Identifying potential gaps in screening and managing dyslipidemia could help to develop a framework for CVD management in this region. Among dyslipidemias, familial hypercholesterolemia (FH) is a risk factor for premature CVD. Data on FH in Sri Lanka, a South Asian country, are sparse. This report is the first to identify and address problems associated with FH in Sri Lanka. It provides insight into the practices employed within the country and helps assess potential barriers in managing patients with FH.</p>\",\"PeriodicalId\":15392,\"journal\":{\"name\":\"Journal of clinical lipidology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical lipidology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jacl.2025.06.025\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jacl.2025.06.025","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Familial hypercholesterolemia in Sri Lanka: Addressing evidence gaps and paving the road ahead.
In recent years, South Asia has witnessed a staggering increase in the rate of cardiovascular (CV) deaths, overburdening healthcare systems in this low- to middle-income region. Dyslipidemia is a major risk factor for cardiovascular disease (CVD). Identifying potential gaps in screening and managing dyslipidemia could help to develop a framework for CVD management in this region. Among dyslipidemias, familial hypercholesterolemia (FH) is a risk factor for premature CVD. Data on FH in Sri Lanka, a South Asian country, are sparse. This report is the first to identify and address problems associated with FH in Sri Lanka. It provides insight into the practices employed within the country and helps assess potential barriers in managing patients with FH.
期刊介绍：
Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner.
Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
